Search clinical trials for: Galectin

Total 59 results

Izmir Katip Celebi University

Recruiting

Evaluation of Salivary Galectin-8, Galectin-9 and RANKL Levels of Individuals With Different Periodontal Diseases

Periodontal Diseases

Turkey
John Paul II Hospital, Krakow

Recruiting

New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis

Transthyretin Amyloidosis

Poland
Assiut University

Not yet recruiting

Evaluation of Galectin-3 in Serum and Saliva of Pemphigus Patients

Galectin-3 and Pemphigus
Indonesia University
PT. Prodia Stem Cell Indonesia

Not yet recruiting

Umbilical Cord Mesenchymal Stem Cell Improve Cardiac Function on ST-elevation Myocardial Infarction (STEMI) Patients

ST Elevation Myocardial Infarction

Indonesia
Sohag University

Not yet recruiting

Galectin-3 in Papillary Thyroid Carcinoma

Galactin 3-thyroid Carcinoma
Fengyun Wang
Wuhan University

Recruiting

Galectin-3 in Septic and Non-septic Acute Kidney Injury

Sepsis | Acute Kidney Injury

China
Assiut University

Not yet recruiting

Assessment of Galectin-9 in Rheumatoid Arthritis and Its Correlation With Disease Activity

Rheumatoid Arthritis
Cairo University

Recruiting

Evaluation of Galectin-3 Levels in GCF And Saliva of Patients With Different Periodontal Diseases

Periodontal Diseases

Egypt
Assiut University

Not yet recruiting

Diagnostic Values of Galectin-3, Soluble ST2 and BNP in Predicting the Clinical Outcome of ST-Segment Elevation Myocardial Infarction Patients

ST Elevation Myocardial Infarction | Stable Angina | HF - Heart Failure
Bioxytran Inc.
ALKE RESEARCH PRIVATE LIMITED; Research Consultancy

Not yet recruiting

PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19 (PROTECT)

COVID-19 | SARS-CoV2 Infection | Cytokine Release Syndrome | COVID-19 Respiratory Infection | COVID-19 Pandemic
Asklepios Neurological Clinic Bad Salzhausen
Asklepios Schlossberg Clinic Bad Koenig

Recruiting

Galectin and Respiratory Weaning (Gal-3)

Galectin-3 During Respiratory Weaning

Germany
National Taiwan University Hospital

Recruiting

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

Thyroid Cancer | Papillary Thyroid Cancer | Follicular Thyroid Cancer

Taiwan
Semmelweis University
University of Pecs

Not yet recruiting

The Role of Galectins in the Non-invasive Diagnosis of Endometriosis

Endometriosis | Endometriosis Ovary | Endometriosis Rectovaginal Septum
Centre Hospitalier Régional d'Orléans

Recruiting

Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated. (ATGALIG-HIV)

HIV Infections | Autophagy | Galectins | Highly Active Antiretroviral Therapy

France
General Practitioners Research Institute
G3 Pharmaceuticals

Enrolling by invitation

G3P-01 in Volunteers With Elevated Galectin-3 (Galaxy)

Healthy Aging | Galectin 3

Netherlands
Galecto Biotech AB
Hoffmann-La Roche; Linical Europe GmbH

Active, not recruiting

A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).

Non-Small Cell Lung Cancer

Spain, Poland, France
National Taiwan University Hospital

Completed

Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3

Thyroid Cancer

Taiwan
Fayoum University

Completed

Galectin Role in Periodontal Disease

Periodontitis | Gingivitis

Egypt
Julie Dawson

Suspended

Measurement Of NT-proBNP to Predict Outcomes in Surgery (MOBOS)

Vascular Surgical Procedure

United Kingdom
Galectin Therapeutics Inc.

Active, not recruiting

Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE)

Cirrhosis | NASH - Nonalcoholic Steatohepatitis | Prevention of Esophageal Varices

United States, France, Spain, Australia, Canada, Israel, Puerto Rico, Belgium, Argentina, Chile, Germany, Korea, Republic of, Mexico, Poland, United Kingdom
Assiut University

Completed

Serum Galectin-3 as a Marker of Human Papillomavirus Infection

Human Papillomavirus Infection

Egypt
Necmettin Erbakan University

Completed

A Serum Galectin-3 Levels in Placenta Accreta Spectrum Pregnancies

Placenta Accreta, Third Trimester

Turkey
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute

Withdrawn

GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients

Metastatic Melanoma | Head and Neck Squamous Cell Carcinoma

United States
Providence Health & Services
Galectin Therapeutics Inc.

Completed

GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients

Melanoma | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck

United States
Galecto Biotech AB
Syneos Health; bioRASI, LLC

Completed

A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF)

United States, Spain, Israel, France, United Kingdom, Australia, Italy, Germany, Canada, Belgium, Georgia, Ireland, Poland, Ukraine
Galecto Biotech AB
Comac Medical

Active, not recruiting

A Single and Repeat Dose Trial in Participants With Hepatic Impairment

Hepatic Impairment

Bulgaria
Assiut University

Completed

Galectin-3 and Placenta Accreta

Placenta Accreta

Egypt
Aydin Adnan Menderes University

Completed

GCF Galectin-3 and Interleukin-1beta Levels in Periodontitis.

Periodontitis | Periodontal Inflammation

Turkey
Galectin Therapeutics Inc.

Completed

A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment

Hepatic Impairment

United States
Recep Tayyip Erdogan University Training and Research...

Completed

Galectin-3 Level in Ankylosing Spondylitis Patients

Ankylosing Spondylitis
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Galectin-3 Blockade in Patients With High Blood Pressure

Hypertension

United States
Galecto Biotech AB
Covance

Withdrawn

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Non-alcoholic Steatohepatitis (NASH)
University of Messina

Completed

Influence of Periodontitis and Coronary Heart Disease on Galectin-3

Periodontal Diseases

Italy
Galectin Therapeutics Inc.
Dr. Naga Chalasani, MD, Indiana University; Dr. Stephen A. Harrison, MD, Brooke...

Completed

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis (NASH-CX)

Hypertension, Portal

United States
Galectin Therapeutics Inc.

Completed

Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis (NASH-FX)

Nonalcoholic Steatohepatitis

United States
Assiut University

Unknown

Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage

Systemic Lupus Erythematosus
Galectin Therapeutics Inc.

Completed

An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis

Psoriasis

United States
Taipei City Hospital

Completed

Correlational Study on the Biomarkers Application to the Prediction and Diagnosis of Cardiovascular Diseases

Stable Angina

Taiwan
Medical University of Warsaw

Unknown

Biomarkers for Risk Stratification After STEMI

Pathologic Processes | Heart Diseases | Cardiovascular Diseases | Heart Failure | Biomarkers | ST Segment Elevation Myocardial Infarction | Primary Percutaneous Coronary Intervention

Poland
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics...

Completed

Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
Cliniques universitaires Saint-Luc- Université...

Terminated

Peptide Vaccinations Plus GM-CT-01 in Melanoma

Metastatic Melanoma

Belgium
Medical University of Warsaw

Unknown

ARrhythmias in MYocarditis (ARMY)

Heart Failure | Myocarditis | Sudden Cardiac Death | Cardiomyopathy | Arrythmia | Biomarker | Endomyocardial Biopsy

Poland
Massachusetts General Hospital

Unknown

Blocking Extracellular Galectin-3 in Patients With Osteoarthritis

Osteoarthritis

United States
Galectin Therapeutics Inc.

Withdrawn

A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

Colorectal Cancer

Israel
Assiut University

Unknown

Galectin-3 for Thromboembolic Formation in Patients With Atrial Fibrillation CHA₂DS₂-VASc Scoring

Stroke | Atrial Fibrillation
Hospital Sao Rafael

Completed

Galectin-3 as a Biomarker in Patients With Chagas Disease

Chagas Disease

Brazil
Galectin Therapeutics Inc.

Withdrawn

Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer

Gallbladder Cancer | Cancer of the Bile Duct

United States
Assiut University

Unknown

Galectin-3 in Patients With Endometriosis

Endometriosis

Egypt
Medical University of Warsaw

Unknown

Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation (STORM)

Heart Failure | Ventricular Tachycardia | Ventricular Dysfunction

Poland
University Hospital, Rouen

Completed

Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter (Galectins)

Goiter, Nodular

France

Search clinical trials for: Galectin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations